Lisata Therapeutics, Inc. (LSTA)
1.05
+0.01
(+0.96%)
USD |
NASDAQ |
Oct 21, 16:00
1.05
0.00 (0.00%)
After-Hours: 18:13
Lisata Therapeutics EPS Diluted (Quarterly) : -0.3217 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3217 |
| March 31, 2026 | -0.4984 |
| December 31, 2025 | -0.3344 |
| September 30, 2025 | -0.4863 |
| June 30, 2025 | -0.5414 |
| March 31, 2025 | -0.5492 |
| December 31, 2024 | -0.5486 |
| September 30, 2024 | -0.5925 |
| June 30, 2024 | -0.6071 |
| March 31, 2024 | -0.6512 |
| December 31, 2023 | -0.6591 |
| September 30, 2023 | -0.6462 |
| June 30, 2023 | -0.5021 |
| March 31, 2023 | -0.7746 |
| December 31, 2022 | -0.762 |
| September 30, 2022 | -7.875 |
| June 30, 2022 | -1.642 |
| March 31, 2022 | -1.047 |
| December 31, 2021 | -1.705 |
| September 30, 2021 | -1.743 |
| June 30, 2021 | -1.432 |
| March 31, 2021 | -2.872 |
| December 31, 2020 | -4.200 |
| September 30, 2020 | -4.297 |
| June 30, 2020 | 7.526 |
| Date | Value |
|---|---|
| March 31, 2020 | -5.634 |
| December 31, 2019 | -7.107 |
| September 30, 2019 | -7.057 |
| June 30, 2019 | -7.418 |
| March 31, 2019 | -6.533 |
| December 31, 2018 | -5.415 |
| September 30, 2018 | -5.465 |
| June 30, 2018 | -6.30 |
| March 31, 2018 | -7.82 |
| December 31, 2017 | -4.355 |
| September 30, 2017 | -5.655 |
| June 30, 2017 | 65.10 |
| March 31, 2017 | -16.74 |
| December 31, 2016 | -10.93 |
| September 30, 2016 | -16.35 |
| June 30, 2016 | -199.50 |
| March 31, 2016 | -31.50 |
| December 31, 2015 | -88.50 |
| September 30, 2015 | -31.50 |
| June 30, 2015 | -57.00 |
| March 31, 2015 | -76.50 |
| December 31, 2014 | -48.00 |
| September 30, 2014 | -72.00 |
| June 30, 2014 | -60.00 |
| March 31, 2014 | -73.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.929M |
| Total Expenses (Quarterly) | 2.929M |
| Enterprise Value | -1.213M |
| Earnings Yield | -156.3% |
| Normalized Earnings Yield | -156.27 |